omeprazole has been researched along with artemisinin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Ashton, M; Bertilsson, L; Dinh, XH; Le, DC; Lykkesfeldt, J; Nguyen, DS; Nguyen, TN; Nguyen, VH; Svensson, US; Trinh, NH | 1 |
Ashton, M; Bertilsson, L; Hai, TN; Mihara, K; Svensson, US; Tybring, G | 1 |
4 other study(ies) available for omeprazole and artemisinin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Artemisinin induces omeprazole metabolism in human beings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antimalarials; Area Under Curve; Artemisinins; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Reference Values; Sesquiterpenes; Time Factors | 1998 |
Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antimalarials; Area Under Curve; Artemisinins; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Male; Mixed Function Oxygenases; Omeprazole; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 1999 |